RT @_Anesthesiology: @altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Compli…
RT @_Anesthesiology: @altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Compli…
RT @_Anesthesiology: @altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Compli…
RT @_Anesthesiology: @altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Compli…
RT @_Anesthesiology: @altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Compli…
@altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis https://t.co/5RmiDYucEu https://t.co/VECJftCAsh
@_jaj Yes, significant cause of post operative complications, 30% relative risk reduction with Sugammadex over Neostigmine as suggested by STRONGER trial. Economic reasons rather than clinical, limiting choice in many centres. https://t.co/iKGNkp4cfl
Should sugammadex become the standard of care for NMB reversal? More evidence of significant PPC reduction from: "Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER)" https://t.co/2Kwr3L
RT @drbencb: A very interesting database analysis - sugammadex was associated with an astonishing 47% relative reduction in postop pneumoni…
RT @drbencb: A very interesting database analysis - sugammadex was associated with an astonishing 47% relative reduction in postop pneumoni…
A very interesting database analysis - sugammadex was associated with an astonishing 47% relative reduction in postop pneumonia. Congrats @sachinkheterpal @MPOGASPIRE. Some implications for composite PPC outcome in @INSPIRE_Trial @denny_levett as other PP
More effective reversal of intraoperative muscle paralysis after surgery appears to reduce pulmonary complications of surgery. Findings from a matched observation study. Time for a large RCT. @SnappStudy #pneumonia #surgery #anesthesiology https://t.co/8
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @icugasdoc: #EBPOMLondon2020: @LeifSaager reports a 30% reduced risk of post-op pulmonary complications if reversed with sugammadex ra…
This seems big.
RT @icugasdoc: #EBPOMLondon2020: @LeifSaager reports a 30% reduced risk of post-op pulmonary complications if reversed with sugammadex ra…
RT @icugasdoc: #EBPOMLondon2020: @LeifSaager reports a 30% reduced risk of post-op pulmonary complications if reversed with sugammadex ra…
RT @icugasdoc: #EBPOMLondon2020: @LeifSaager reports a 30% reduced risk of post-op pulmonary complications if reversed with sugammadex ra…
#EBPOMLondon2020: @LeifSaager reports a 30% reduced risk of post-op pulmonary complications if reversed with sugammadex rather than neostigmine 🤯 https://t.co/DA6HamkwMY https://t.co/mB2c5k4Au3
Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER):A Multicenter Matched Cohort Analysis https://t.co/LTATG9G76y
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
https://t.co/E4kp05iHpd 筋弛緩のリバースとしてneostigmineとsugammadexとを比較した後ろ向き研究 多変量解析の結果は、sugammadexはneostigmineと比べて術後肺合併症(aOR:0.70[0.63-0.77])肺炎(aOR:0.53[0.44-0.62])、呼吸不全(aOR:0.45[0.37-0.56])が低かった #当麻_筋弛緩
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
RT @_Anesthesiology: In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% re…
In a noncardiac surgery study, #sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% reduced risk of pneumonia, and a 55% reduced risk of respiratory failure compared to neostigmine https://t.co/1gZkQvz47V #visualabstract htt
RT @AbadGurumeta: Sugammadex vs neostigmine Sugammadex reduce 30% risk pulmonary complications, 47% risk of pneumonia and 55% risk of res…
RT @AbadGurumeta: Sugammadex vs neostigmine Sugammadex reduce 30% risk pulmonary complications, 47% risk of pneumonia and 55% risk of res…
RT @AbadGurumeta: Sugammadex vs neostigmine Sugammadex reduce 30% risk pulmonary complications, 47% risk of pneumonia and 55% risk of res…
Sugammadex vs neostigmine Sugammadex reduce 30% risk pulmonary complications, 47% risk of pneumonia and 55% risk of respiratory failure https://t.co/ZHmWoxNkkC
Hey friends!! Non-COVID things are still out there - don't miss this one!!!
#Sugammadex versus #Neostigmine for #Reversal of #Neuromuscular #Blockade and #Postoperative #Pulmonary #Complications ( #STRONGER): A Multicenter Matched Cohort Analysis. https://t.co/dKbRt9q890 https://t.co/XvZgCy3T2e
Great perioperative research ! Likely high impact on standard care
Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER) A Multicenter Matched Cohort Analysis - https://t.co/hHIPtrVw6W https://t.co/opuLF68IbI
RT @AcklandLab: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER):…
Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis. https://t.co/D4zfvkYH1J
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
RT @sachinkheterpal: Collaboration across @MPOGASPIRE showing we may be able to reduce major pulmonary complications by 30% after surgery.…
What about the combination of sugammadex plus neostigmine; they should have synergistic effects!
RT @JBLascarrou: Unfortunately any application in ICU
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
RT @JeremyGueMD: Sugammadex vs Neostigmine: ➡️30% reduced risk of pulmonary complications ➡️47% reduced risk of pneumonia ➡️55% reduced ri…
Unfortunately any application in ICU
RT @sachinkheterpal: Collaboration across @MPOGASPIRE showing we may be able to reduce major pulmonary complications by 30% after surgery.…
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
Collaboration across @MPOGASPIRE showing we may be able to reduce major pulmonary complications by 30% after surgery. More research needed to validate the findings, but anesthesiologists and surgeons should discuss sugammadex as an option https://t.co/1lB9
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
Sugammadex vs Neostigmine: ➡️30% reduced risk of pulmonary complications ➡️47% reduced risk of pneumonia ➡️55% reduced risk of respiratory failure
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
Interesting article! But it starts with info about inc'd mortality/ cost related to pulmonary complications. I wish the paper included those data _in the studied population_. That, after all, is actually the major barrier to increased use of sugammadex.
RT @_Anesthesiology: New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromu…
Observational matched cohort study of noncardiac surgery Sugammadex associated with 📌 30% reduced risk of pulmonary complications 📌 47% reduced risk of pneumonia 📌 55% reduced risk of respiratory failure compared to neostigmine.
New original investigation from @sachinkheterpal @umichmedicine: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis https://t.co/NWXCi3nKY6
In a multicenter observational matched cohort study of noncardiac surgery, sugammadex was associated with a 30% reduced risk of pulmonary complications, a 47% reduced risk of pneumonia, and a 55% reduced risk of respiratory failure compared to neostigmine